Business Insider1mon
Analysts Have Conflicting Sentiments on These Healthcare Companies: Corbus Pharmaceuticals (CRBP), Genmab (GMAB) and CVRx (CVRX)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Corbus Pharmaceuticals (CRBP – Research Report), Genmab (GMAB – Research Report) and CVRx (CVRX ...
Business Insider13d
Corbus Pharmaceuticals (CRBP) Gets a Buy from RBC Capital
RBC Capital analyst Brian Abrahams maintained a Buy rating on Corbus Pharmaceuticals (CRBP – Research Report) yesterday and set a price target of $65.00. The company’s shares closed yesterday ...
ETF Daily News9d
What is B. Riley’s Estimate for CRBP Q1 Earnings?
Shares of CRBP opened at $6.79 on Friday. The stock has a 50-day moving average of $9.44 and a two-hundred day moving average of $18.72. Corbus Pharmaceuticals has a one year low of $6.38 and a ...